Global Veterinary Vaccine Market Analysis and Forecast 2024-2030
Summary
Vaccines are products designed to trigger protective immune responses and prepare the immune system to fight future infections from disease-causing agents. Vaccines stimulate the immune system’s production of antibodies that identify and destroy disease-causing organisms that enter the body. Vaccines provide immunity against one or several diseases that can lessen the severity or prevent certain diseases altogether. In this report, we study the vaccine used for animals.
According to APO Research, The global Veterinary Vaccine market is projected to grow from US$ million in 2024 to US$ million by 2030, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.
The US & Canada market for Veterinary Vaccine is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
Asia-Pacific market for Veterinary Vaccine is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
The China market for Veterinary Vaccine is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
Europe market for Veterinary Vaccine is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
The major global manufacturers of Veterinary Vaccine include Merck, Zoetis, Boehringer Ingelheim, Ceva, CAHIC, HVRI, Ringpu Biology, Yebio and DHN, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report presents an overview of global market for Veterinary Vaccine, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.
This report researches the key producers of Veterinary Vaccine, also provides the sales of main regions and countries. Of the upcoming market potential for Veterinary Vaccine, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Veterinary Vaccine sales, revenue, market share and industry ranking of main manufacturers, data from 2019 to 2024. Identification of the major stakeholders in the global Veterinary Vaccine market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2019 to 2030. Evaluation and forecast the market size for Veterinary Vaccine sales, projected growth trends, production technology, application and end-user industry.
Veterinary Vaccine segment by Company
1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Veterinary Vaccine market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Veterinary Vaccine and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Veterinary Vaccine.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Sales (consumption), revenue of Veterinary Vaccine in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 4: Detailed analysis of Veterinary Vaccine manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Veterinary Vaccine sales, revenue, price, gross margin, and recent development, etc.
Chapter 8: North America (US & Canada) by type, by application and by country, sales, and revenue for each segment.
Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.
Chapter 10: China type, by application, sales, and revenue for each segment.
Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.
Chapter 12: Middle East, Africa, and Latin America type, by application and by country, sales, and revenue for each segment.
Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.
Chapter 14: The main concluding insights of the report.
Vaccines are products designed to trigger protective immune responses and prepare the immune system to fight future infections from disease-causing agents. Vaccines stimulate the immune system’s production of antibodies that identify and destroy disease-causing organisms that enter the body. Vaccines provide immunity against one or several diseases that can lessen the severity or prevent certain diseases altogether. In this report, we study the vaccine used for animals.
According to APO Research, The global Veterinary Vaccine market is projected to grow from US$ million in 2024 to US$ million by 2030, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.
The US & Canada market for Veterinary Vaccine is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
Asia-Pacific market for Veterinary Vaccine is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
The China market for Veterinary Vaccine is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
Europe market for Veterinary Vaccine is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
The major global manufacturers of Veterinary Vaccine include Merck, Zoetis, Boehringer Ingelheim, Ceva, CAHIC, HVRI, Ringpu Biology, Yebio and DHN, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report presents an overview of global market for Veterinary Vaccine, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.
This report researches the key producers of Veterinary Vaccine, also provides the sales of main regions and countries. Of the upcoming market potential for Veterinary Vaccine, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Veterinary Vaccine sales, revenue, market share and industry ranking of main manufacturers, data from 2019 to 2024. Identification of the major stakeholders in the global Veterinary Vaccine market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2019 to 2030. Evaluation and forecast the market size for Veterinary Vaccine sales, projected growth trends, production technology, application and end-user industry.
Veterinary Vaccine segment by Company
- Merck
- Zoetis
- Boehringer Ingelheim
- Ceva
- CAHIC
- HVRI
- Ringpu Biology
- Yebio
- DHN
- WINSUN
- Elanco
- Virbac
- Jinyu Bio-Technology
- ChengDu Tecbond
- CAVAC
- Kyoto Biken Laboratories
- FATRO
- Vaksindo
- Bio-Labs
- Avimex Animal Health
- MEVAC
- Biovac
- Atafen
- Dyntec
- BioTestLab
- RVSRI
- Medion
- Live Attenuated Vaccines
- Inactivated Vaccines
- Others
- Livestock
- Swine
- Chicken
- Dog & Cat
- Others
- North America
- U.S.
- Canada
- Europe
- Germany
- France
- U.K.
- Italy
- Russia
- Asia-Pacific
- China
- Japan
- South Korea
- India
- Australia
- China Taiwan
- Indonesia
- Thailand
- Malaysia
- Latin America
- Mexico
- Brazil
- Argentina
- Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Veterinary Vaccine market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Veterinary Vaccine and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Veterinary Vaccine.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Sales (consumption), revenue of Veterinary Vaccine in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 4: Detailed analysis of Veterinary Vaccine manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Veterinary Vaccine sales, revenue, price, gross margin, and recent development, etc.
Chapter 8: North America (US & Canada) by type, by application and by country, sales, and revenue for each segment.
Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.
Chapter 10: China type, by application, sales, and revenue for each segment.
Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.
Chapter 12: Middle East, Africa, and Latin America type, by application and by country, sales, and revenue for each segment.
Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.
Chapter 14: The main concluding insights of the report.
1 MARKET OVERVIEW
1.1 Product Definition
1.2 Veterinary Vaccine Market by Type
1.2.1 Global Veterinary Vaccine Market Size by Type, 2019 VS 2023 VS 2030
1.2.2 Live Attenuated Vaccines
1.2.3 Inactivated Vaccines
1.2.4 Others
1.3 Veterinary Vaccine Market by Application
1.3.1 Global Veterinary Vaccine Market Size by Application, 2019 VS 2023 VS 2030
1.3.2 Livestock
1.3.3 Swine
1.3.4 Chicken
1.3.5 Dog & Cat
1.3.6 Others
1.4 Assumptions and Limitations
1.5 Study Goals and Objectives
2 VETERINARY VACCINE MARKET DYNAMICS
2.1 Veterinary Vaccine Industry Trends
2.2 Veterinary Vaccine Industry Drivers
2.3 Veterinary Vaccine Industry Opportunities and Challenges
2.4 Veterinary Vaccine Industry Restraints
3 GLOBAL MARKET GROWTH PROSPECTS
3.1 Global Veterinary Vaccine Revenue Estimates and Forecasts (2019-2030)
3.2 Global Veterinary Vaccine Revenue by Region
3.2.1 Global Veterinary Vaccine Revenue by Region: 2019 VS 2023 VS 2030
3.2.2 Global Veterinary Vaccine Revenue by Region (2019-2024)
3.2.3 Global Veterinary Vaccine Revenue by Region (2025-2030)
3.2.4 Global Veterinary Vaccine Revenue Market Share by Region (2019-2030)
3.3 Global Veterinary Vaccine Sales Estimates and Forecasts 2019-2030
3.4 Global Veterinary Vaccine Sales by Region
3.4.1 Global Veterinary Vaccine Sales by Region: 2019 VS 2023 VS 2030
3.4.2 Global Veterinary Vaccine Sales by Region (2019-2024)
3.4.3 Global Veterinary Vaccine Sales by Region (2025-2030)
3.4.4 Global Veterinary Vaccine Sales Market Share by Region (2019-2030)
3.5 US & Canada
3.6 Europe
3.7 China
3.8 Asia (Excluding China)
3.9 Middle East, Africa and Latin America
4 MARKET COMPETITIVE LANDSCAPE BY MANUFACTURERS
4.1 Global Veterinary Vaccine Revenue by Manufacturers
4.1.1 Global Veterinary Vaccine Revenue by Manufacturers (2019-2024)
4.1.2 Global Veterinary Vaccine Revenue Market Share by Manufacturers (2019-2024)
4.1.3 Global Veterinary Vaccine Manufacturers Revenue Share Top 10 and Top 5 in 2023
4.2 Global Veterinary Vaccine Sales by Manufacturers
4.2.1 Global Veterinary Vaccine Sales by Manufacturers (2019-2024)
4.2.2 Global Veterinary Vaccine Sales Market Share by Manufacturers (2019-2024)
4.2.3 Global Veterinary Vaccine Manufacturers Sales Share Top 10 and Top 5 in 2023
4.3 Global Veterinary Vaccine Sales Price by Manufacturers (2019-2024)
4.4 Global Veterinary Vaccine Key Manufacturers Ranking, 2022 VS 2023 VS 2024
4.5 Global Veterinary Vaccine Key Manufacturers Manufacturing Sites & Headquarters
4.6 Global Veterinary Vaccine Manufacturers, Product Type & Application
4.7 Global Veterinary Vaccine Manufacturers Commercialization Time
4.8 Market Competitive Analysis
4.8.1 Global Veterinary Vaccine Market CR5 and HHI
4.8.2 2023 Veterinary Vaccine Tier 1, Tier 2, and Tier
5 VETERINARY VACCINE MARKET BY TYPE
5.1 Global Veterinary Vaccine Revenue by Type
5.1.1 Global Veterinary Vaccine Revenue by Type (2019 VS 2023 VS 2030)
5.1.2 Global Veterinary Vaccine Revenue by Type (2019-2030) & (US$ Million)
5.1.3 Global Veterinary Vaccine Revenue Market Share by Type (2019-2030)
5.2 Global Veterinary Vaccine Sales by Type
5.2.1 Global Veterinary Vaccine Sales by Type (2019 VS 2023 VS 2030)
5.2.2 Global Veterinary Vaccine Sales by Type (2019-2030) & (M Doses)
5.2.3 Global Veterinary Vaccine Sales Market Share by Type (2019-2030)
5.3 Global Veterinary Vaccine Price by Type
6 VETERINARY VACCINE MARKET BY APPLICATION
6.1 Global Veterinary Vaccine Revenue by Application
6.1.1 Global Veterinary Vaccine Revenue by Application (2019 VS 2023 VS 2030)
6.1.2 Global Veterinary Vaccine Revenue by Application (2019-2030) & (US$ Million)
6.1.3 Global Veterinary Vaccine Revenue Market Share by Application (2019-2030)
6.2 Global Veterinary Vaccine Sales by Application
6.2.1 Global Veterinary Vaccine Sales by Application (2019 VS 2023 VS 2030)
6.2.2 Global Veterinary Vaccine Sales by Application (2019-2030) & (M Doses)
6.2.3 Global Veterinary Vaccine Sales Market Share by Application (2019-2030)
6.3 Global Veterinary Vaccine Price by Application
7 COMPANY PROFILES
7.1 Merck
7.1.1 Merck Comapny Information
7.1.2 Merck Business Overview
7.1.3 Merck Veterinary Vaccine Sales, Revenue, Price and Gross Margin (2019-2024)
7.1.4 Merck Veterinary Vaccine Product Portfolio
7.1.5 Merck Recent Developments
7.2 Zoetis
7.2.1 Zoetis Comapny Information
7.2.2 Zoetis Business Overview
7.2.3 Zoetis Veterinary Vaccine Sales, Revenue, Price and Gross Margin (2019-2024)
7.2.4 Zoetis Veterinary Vaccine Product Portfolio
7.2.5 Zoetis Recent Developments
7.3 Boehringer Ingelheim
7.3.1 Boehringer Ingelheim Comapny Information
7.3.2 Boehringer Ingelheim Business Overview
7.3.3 Boehringer Ingelheim Veterinary Vaccine Sales, Revenue, Price and Gross Margin (2019-2024)
7.3.4 Boehringer Ingelheim Veterinary Vaccine Product Portfolio
7.3.5 Boehringer Ingelheim Recent Developments
7.4 Ceva
7.4.1 Ceva Comapny Information
7.4.2 Ceva Business Overview
7.4.3 Ceva Veterinary Vaccine Sales, Revenue, Price and Gross Margin (2019-2024)
7.4.4 Ceva Veterinary Vaccine Product Portfolio
7.4.5 Ceva Recent Developments
7.5 CAHIC
7.5.1 CAHIC Comapny Information
7.5.2 CAHIC Business Overview
7.5.3 CAHIC Veterinary Vaccine Sales, Revenue, Price and Gross Margin (2019-2024)
7.5.4 CAHIC Veterinary Vaccine Product Portfolio
7.5.5 CAHIC Recent Developments
7.6 HVRI
7.6.1 HVRI Comapny Information
7.6.2 HVRI Business Overview
7.6.3 HVRI Veterinary Vaccine Sales, Revenue, Price and Gross Margin (2019-2024)
7.6.4 HVRI Veterinary Vaccine Product Portfolio
7.6.5 HVRI Recent Developments
7.7 Ringpu Biology
7.7.1 Ringpu Biology Comapny Information
7.7.2 Ringpu Biology Business Overview
7.7.3 Ringpu Biology Veterinary Vaccine Sales, Revenue, Price and Gross Margin (2019-2024)
7.7.4 Ringpu Biology Veterinary Vaccine Product Portfolio
7.7.5 Ringpu Biology Recent Developments
7.8 Yebio
7.8.1 Yebio Comapny Information
7.8.2 Yebio Business Overview
7.8.3 Yebio Veterinary Vaccine Sales, Revenue, Price and Gross Margin (2019-2024)
7.8.4 Yebio Veterinary Vaccine Product Portfolio
7.8.5 Yebio Recent Developments
7.9 DHN
7.9.1 DHN Comapny Information
7.9.2 DHN Business Overview
7.9.3 DHN Veterinary Vaccine Sales, Revenue, Price and Gross Margin (2019-2024)
7.9.4 DHN Veterinary Vaccine Product Portfolio
7.9.5 DHN Recent Developments
7.10 WINSUN
7.10.1 WINSUN Comapny Information
7.10.2 WINSUN Business Overview
7.10.3 WINSUN Veterinary Vaccine Sales, Revenue, Price and Gross Margin (2019-2024)
7.10.4 WINSUN Veterinary Vaccine Product Portfolio
7.10.5 WINSUN Recent Developments
7.11 Elanco
7.11.1 Elanco Comapny Information
7.11.2 Elanco Business Overview
7.11.3 Elanco Veterinary Vaccine Sales, Revenue, Price and Gross Margin (2019-2024)
7.11.4 Elanco Veterinary Vaccine Product Portfolio
7.11.5 Elanco Recent Developments
7.12 Virbac
7.12.1 Virbac Comapny Information
7.12.2 Virbac Business Overview
7.12.3 Virbac Veterinary Vaccine Sales, Revenue, Price and Gross Margin (2019-2024)
7.12.4 Virbac Veterinary Vaccine Product Portfolio
7.12.5 Virbac Recent Developments
7.13 Jinyu Bio-Technology
7.13.1 Jinyu Bio-Technology Comapny Information
7.13.2 Jinyu Bio-Technology Business Overview
7.13.3 Jinyu Bio-Technology Veterinary Vaccine Sales, Revenue, Price and Gross Margin (2019-2024)
7.13.4 Jinyu Bio-Technology Veterinary Vaccine Product Portfolio
7.13.5 Jinyu Bio-Technology Recent Developments
7.14 ChengDu Tecbond
7.14.1 ChengDu Tecbond Comapny Information
7.14.2 ChengDu Tecbond Business Overview
7.14.3 ChengDu Tecbond Veterinary Vaccine Sales, Revenue, Price and Gross Margin (2019-2024)
7.14.4 ChengDu Tecbond Veterinary Vaccine Product Portfolio
7.14.5 ChengDu Tecbond Recent Developments
7.15 CAVAC
7.15.1 CAVAC Comapny Information
7.15.2 CAVAC Business Overview
7.15.3 CAVAC Veterinary Vaccine Sales, Revenue, Price and Gross Margin (2019-2024)
7.15.4 CAVAC Veterinary Vaccine Product Portfolio
7.15.5 CAVAC Recent Developments
7.16 Kyoto Biken Laboratories
7.16.1 Kyoto Biken Laboratories Comapny Information
7.16.2 Kyoto Biken Laboratories Business Overview
7.16.3 Kyoto Biken Laboratories Veterinary Vaccine Sales, Revenue, Price and Gross Margin (2019-2024)
7.16.4 Kyoto Biken Laboratories Veterinary Vaccine Product Portfolio
7.16.5 Kyoto Biken Laboratories Recent Developments
7.17 FATRO
7.17.1 FATRO Comapny Information
7.17.2 FATRO Business Overview
7.17.3 FATRO Veterinary Vaccine Sales, Revenue, Price and Gross Margin (2019-2024)
7.17.4 FATRO Veterinary Vaccine Product Portfolio
7.17.5 FATRO Recent Developments
7.18 Vaksindo
7.18.1 Vaksindo Comapny Information
7.18.2 Vaksindo Business Overview
7.18.3 Vaksindo Veterinary Vaccine Sales, Revenue, Price and Gross Margin (2019-2024)
7.18.4 Vaksindo Veterinary Vaccine Product Portfolio
7.18.5 Vaksindo Recent Developments
7.19 Bio-Labs
7.19.1 Bio-Labs Comapny Information
7.19.2 Bio-Labs Business Overview
7.19.3 Bio-Labs Veterinary Vaccine Sales, Revenue, Price and Gross Margin (2019-2024)
7.19.4 Bio-Labs Veterinary Vaccine Product Portfolio
7.19.5 Bio-Labs Recent Developments
7.20 Avimex Animal Health
7.20.1 Avimex Animal Health Comapny Information
7.20.2 Avimex Animal Health Business Overview
7.20.3 Avimex Animal Health Veterinary Vaccine Sales, Revenue, Price and Gross Margin (2019-2024)
7.20.4 Avimex Animal Health Veterinary Vaccine Product Portfolio
7.20.5 Avimex Animal Health Recent Developments
7.21 MEVAC
7.21.1 MEVAC Comapny Information
7.21.2 MEVAC Business Overview
7.21.3 MEVAC Veterinary Vaccine Sales, Revenue, Price and Gross Margin (2019-2024)
7.21.4 MEVAC Veterinary Vaccine Product Portfolio
7.21.5 MEVAC Recent Developments
7.22 Biovac
7.22.1 Biovac Comapny Information
7.22.2 Biovac Business Overview
7.22.3 Biovac Veterinary Vaccine Sales, Revenue, Price and Gross Margin (2019-2024)
7.22.4 Biovac Veterinary Vaccine Product Portfolio
7.22.5 Biovac Recent Developments
7.23 Atafen
7.23.1 Atafen Comapny Information
7.23.2 Atafen Business Overview
7.23.3 Atafen Veterinary Vaccine Sales, Revenue, Price and Gross Margin (2019-2024)
7.23.4 Atafen Veterinary Vaccine Product Portfolio
7.23.5 Atafen Recent Developments
7.24 Dyntec
7.24.1 Dyntec Comapny Information
7.24.2 Dyntec Business Overview
7.24.3 Dyntec Veterinary Vaccine Sales, Revenue, Price and Gross Margin (2019-2024)
7.24.4 Dyntec Veterinary Vaccine Product Portfolio
7.24.5 Dyntec Recent Developments
7.25 BioTestLab
7.25.1 BioTestLab Comapny Information
7.25.2 BioTestLab Business Overview
7.25.3 BioTestLab Veterinary Vaccine Sales, Revenue, Price and Gross Margin (2019-2024)
7.25.4 BioTestLab Veterinary Vaccine Product Portfolio
7.25.5 BioTestLab Recent Developments
7.26 RVSRI
7.26.1 RVSRI Comapny Information
7.26.2 RVSRI Business Overview
7.26.3 RVSRI Veterinary Vaccine Sales, Revenue, Price and Gross Margin (2019-2024)
7.26.4 RVSRI Veterinary Vaccine Product Portfolio
7.26.5 RVSRI Recent Developments
7.27 Medion
7.27.1 Medion Comapny Information
7.27.2 Medion Business Overview
7.27.3 Medion Veterinary Vaccine Sales, Revenue, Price and Gross Margin (2019-2024)
7.27.4 Medion Veterinary Vaccine Product Portfolio
7.27.5 Medion Recent Developments
8 NORTH AMERICA
8.1 North America Veterinary Vaccine Market Size by Type
8.1.1 North America Veterinary Vaccine Revenue by Type (2019-2030)
8.1.2 North America Veterinary Vaccine Sales by Type (2019-2030)
8.1.3 North America Veterinary Vaccine Price by Type (2019-2030)
8.2 North America Veterinary Vaccine Market Size by Application
8.2.1 North America Veterinary Vaccine Revenue by Application (2019-2030)
8.2.2 North America Veterinary Vaccine Sales by Application (2019-2030)
8.2.3 North America Veterinary Vaccine Price by Application (2019-2030)
8.3 North America Veterinary Vaccine Market Size by Country
8.3.1 North America Veterinary Vaccine Revenue Grow Rate by Country (2019 VS 2023 VS 2030)
8.3.2 North America Veterinary Vaccine Sales by Country (2019 VS 2023 VS 2030)
8.3.3 North America Veterinary Vaccine Price by Country (2019-2030)
8.3.4 U.S.
8.3.5 Canada
9 EUROPE
9.1 Europe Veterinary Vaccine Market Size by Type
9.1.1 Europe Veterinary Vaccine Revenue by Type (2019-2030)
9.1.2 Europe Veterinary Vaccine Sales by Type (2019-2030)
9.1.3 Europe Veterinary Vaccine Price by Type (2019-2030)
9.2 Europe Veterinary Vaccine Market Size by Application
9.2.1 Europe Veterinary Vaccine Revenue by Application (2019-2030)
9.2.2 Europe Veterinary Vaccine Sales by Application (2019-2030)
9.2.3 Europe Veterinary Vaccine Price by Application (2019-2030)
9.3 Europe Veterinary Vaccine Market Size by Country
9.3.1 Europe Veterinary Vaccine Revenue Grow Rate by Country (2019 VS 2023 VS 2030)
9.3.2 Europe Veterinary Vaccine Sales by Country (2019 VS 2023 VS 2030)
9.3.3 Europe Veterinary Vaccine Price by Country (2019-2030)
9.3.4 Germany
9.3.5 France
9.3.6 U.K.
9.3.7 Italy
9.3.8 Russia
10 CHINA
10.1 China Veterinary Vaccine Market Size by Type
10.1.1 China Veterinary Vaccine Revenue by Type (2019-2030)
10.1.2 China Veterinary Vaccine Sales by Type (2019-2030)
10.1.3 China Veterinary Vaccine Price by Type (2019-2030)
10.2 China Veterinary Vaccine Market Size by Application
10.2.1 China Veterinary Vaccine Revenue by Application (2019-2030)
10.2.2 China Veterinary Vaccine Sales by Application (2019-2030)
10.2.3 China Veterinary Vaccine Price by Application (2019-2030)
11 ASIA (EXCLUDING CHINA)
11.1 Asia Veterinary Vaccine Market Size by Type
11.1.1 Asia Veterinary Vaccine Revenue by Type (2019-2030)
11.1.2 Asia Veterinary Vaccine Sales by Type (2019-2030)
11.1.3 Asia Veterinary Vaccine Price by Type (2019-2030)
11.2 Asia Veterinary Vaccine Market Size by Application
11.2.1 Asia Veterinary Vaccine Revenue by Application (2019-2030)
11.2.2 Asia Veterinary Vaccine Sales by Application (2019-2030)
11.2.3 Asia Veterinary Vaccine Price by Application (2019-2030)
11.3 Asia Veterinary Vaccine Market Size by Country
11.3.1 Asia Veterinary Vaccine Revenue Grow Rate by Country (2019 VS 2023 VS 2030)
11.3.2 Asia Veterinary Vaccine Sales by Country (2019 VS 2023 VS 2030)
11.3.3 Asia Veterinary Vaccine Price by Country (2019-2030)
11.3.4 Japan
11.3.5 South Korea
11.3.6 India
11.3.7 Australia
11.3.8 China Taiwan
11.3.9 Southeast Asia
12 MIDDLE EAST, AFRICA AND LATIN AMERICA
12.1 MEALA Veterinary Vaccine Market Size by Type
12.1.1 MEALA Veterinary Vaccine Revenue by Type (2019-2030)
12.1.2 MEALA Veterinary Vaccine Sales by Type (2019-2030)
12.1.3 MEALA Veterinary Vaccine Price by Type (2019-2030)
12.2 MEALA Veterinary Vaccine Market Size by Application
12.2.1 MEALA Veterinary Vaccine Revenue by Application (2019-2030)
12.2.2 MEALA Veterinary Vaccine Sales by Application (2019-2030)
12.2.3 MEALA Veterinary Vaccine Price by Application (2019-2030)
12.3 MEALA Veterinary Vaccine Market Size by Country
12.3.1 MEALA Veterinary Vaccine Revenue Grow Rate by Country (2019 VS 2023 VS 2030)
12.3.2 MEALA Veterinary Vaccine Sales by Country (2019 VS 2023 VS 2030)
12.3.3 MEALA Veterinary Vaccine Price by Country (2019-2030)
12.3.4 Mexico
12.3.5 Brazil
12.3.6 Israel
12.3.7 Argentina
12.3.8 Colombia
12.3.9 Turkey
12.3.10 Saudi Arabia
12.3.11 UAE
13 VALUE CHAIN AND SALES CHANNELS ANALYSIS
13.1 Veterinary Vaccine Value Chain Analysis
13.1.1 Veterinary Vaccine Key Raw Materials
13.1.2 Raw Materials Key Suppliers
13.1.3 Manufacturing Cost Structure
13.1.4 Veterinary Vaccine Production Mode & Process
13.2 Veterinary Vaccine Sales Channels Analysis
13.2.1 Direct Comparison with Distribution Share
13.2.2 Veterinary Vaccine Distributors
13.2.3 Veterinary Vaccine Customers
14 CONCLUDING INSIGHTS
15 APPENDIX
15.1 Reasons for Doing This Study
15.2 Research Methodology
15.3 Research Process
15.4 Authors List of This Report
15.5 Data Source
15.5.1 Secondary Sources
15.5.2 Primary Sources
15.6 Disclaimer
1.1 Product Definition
1.2 Veterinary Vaccine Market by Type
1.2.1 Global Veterinary Vaccine Market Size by Type, 2019 VS 2023 VS 2030
1.2.2 Live Attenuated Vaccines
1.2.3 Inactivated Vaccines
1.2.4 Others
1.3 Veterinary Vaccine Market by Application
1.3.1 Global Veterinary Vaccine Market Size by Application, 2019 VS 2023 VS 2030
1.3.2 Livestock
1.3.3 Swine
1.3.4 Chicken
1.3.5 Dog & Cat
1.3.6 Others
1.4 Assumptions and Limitations
1.5 Study Goals and Objectives
2 VETERINARY VACCINE MARKET DYNAMICS
2.1 Veterinary Vaccine Industry Trends
2.2 Veterinary Vaccine Industry Drivers
2.3 Veterinary Vaccine Industry Opportunities and Challenges
2.4 Veterinary Vaccine Industry Restraints
3 GLOBAL MARKET GROWTH PROSPECTS
3.1 Global Veterinary Vaccine Revenue Estimates and Forecasts (2019-2030)
3.2 Global Veterinary Vaccine Revenue by Region
3.2.1 Global Veterinary Vaccine Revenue by Region: 2019 VS 2023 VS 2030
3.2.2 Global Veterinary Vaccine Revenue by Region (2019-2024)
3.2.3 Global Veterinary Vaccine Revenue by Region (2025-2030)
3.2.4 Global Veterinary Vaccine Revenue Market Share by Region (2019-2030)
3.3 Global Veterinary Vaccine Sales Estimates and Forecasts 2019-2030
3.4 Global Veterinary Vaccine Sales by Region
3.4.1 Global Veterinary Vaccine Sales by Region: 2019 VS 2023 VS 2030
3.4.2 Global Veterinary Vaccine Sales by Region (2019-2024)
3.4.3 Global Veterinary Vaccine Sales by Region (2025-2030)
3.4.4 Global Veterinary Vaccine Sales Market Share by Region (2019-2030)
3.5 US & Canada
3.6 Europe
3.7 China
3.8 Asia (Excluding China)
3.9 Middle East, Africa and Latin America
4 MARKET COMPETITIVE LANDSCAPE BY MANUFACTURERS
4.1 Global Veterinary Vaccine Revenue by Manufacturers
4.1.1 Global Veterinary Vaccine Revenue by Manufacturers (2019-2024)
4.1.2 Global Veterinary Vaccine Revenue Market Share by Manufacturers (2019-2024)
4.1.3 Global Veterinary Vaccine Manufacturers Revenue Share Top 10 and Top 5 in 2023
4.2 Global Veterinary Vaccine Sales by Manufacturers
4.2.1 Global Veterinary Vaccine Sales by Manufacturers (2019-2024)
4.2.2 Global Veterinary Vaccine Sales Market Share by Manufacturers (2019-2024)
4.2.3 Global Veterinary Vaccine Manufacturers Sales Share Top 10 and Top 5 in 2023
4.3 Global Veterinary Vaccine Sales Price by Manufacturers (2019-2024)
4.4 Global Veterinary Vaccine Key Manufacturers Ranking, 2022 VS 2023 VS 2024
4.5 Global Veterinary Vaccine Key Manufacturers Manufacturing Sites & Headquarters
4.6 Global Veterinary Vaccine Manufacturers, Product Type & Application
4.7 Global Veterinary Vaccine Manufacturers Commercialization Time
4.8 Market Competitive Analysis
4.8.1 Global Veterinary Vaccine Market CR5 and HHI
4.8.2 2023 Veterinary Vaccine Tier 1, Tier 2, and Tier
5 VETERINARY VACCINE MARKET BY TYPE
5.1 Global Veterinary Vaccine Revenue by Type
5.1.1 Global Veterinary Vaccine Revenue by Type (2019 VS 2023 VS 2030)
5.1.2 Global Veterinary Vaccine Revenue by Type (2019-2030) & (US$ Million)
5.1.3 Global Veterinary Vaccine Revenue Market Share by Type (2019-2030)
5.2 Global Veterinary Vaccine Sales by Type
5.2.1 Global Veterinary Vaccine Sales by Type (2019 VS 2023 VS 2030)
5.2.2 Global Veterinary Vaccine Sales by Type (2019-2030) & (M Doses)
5.2.3 Global Veterinary Vaccine Sales Market Share by Type (2019-2030)
5.3 Global Veterinary Vaccine Price by Type
6 VETERINARY VACCINE MARKET BY APPLICATION
6.1 Global Veterinary Vaccine Revenue by Application
6.1.1 Global Veterinary Vaccine Revenue by Application (2019 VS 2023 VS 2030)
6.1.2 Global Veterinary Vaccine Revenue by Application (2019-2030) & (US$ Million)
6.1.3 Global Veterinary Vaccine Revenue Market Share by Application (2019-2030)
6.2 Global Veterinary Vaccine Sales by Application
6.2.1 Global Veterinary Vaccine Sales by Application (2019 VS 2023 VS 2030)
6.2.2 Global Veterinary Vaccine Sales by Application (2019-2030) & (M Doses)
6.2.3 Global Veterinary Vaccine Sales Market Share by Application (2019-2030)
6.3 Global Veterinary Vaccine Price by Application
7 COMPANY PROFILES
7.1 Merck
7.1.1 Merck Comapny Information
7.1.2 Merck Business Overview
7.1.3 Merck Veterinary Vaccine Sales, Revenue, Price and Gross Margin (2019-2024)
7.1.4 Merck Veterinary Vaccine Product Portfolio
7.1.5 Merck Recent Developments
7.2 Zoetis
7.2.1 Zoetis Comapny Information
7.2.2 Zoetis Business Overview
7.2.3 Zoetis Veterinary Vaccine Sales, Revenue, Price and Gross Margin (2019-2024)
7.2.4 Zoetis Veterinary Vaccine Product Portfolio
7.2.5 Zoetis Recent Developments
7.3 Boehringer Ingelheim
7.3.1 Boehringer Ingelheim Comapny Information
7.3.2 Boehringer Ingelheim Business Overview
7.3.3 Boehringer Ingelheim Veterinary Vaccine Sales, Revenue, Price and Gross Margin (2019-2024)
7.3.4 Boehringer Ingelheim Veterinary Vaccine Product Portfolio
7.3.5 Boehringer Ingelheim Recent Developments
7.4 Ceva
7.4.1 Ceva Comapny Information
7.4.2 Ceva Business Overview
7.4.3 Ceva Veterinary Vaccine Sales, Revenue, Price and Gross Margin (2019-2024)
7.4.4 Ceva Veterinary Vaccine Product Portfolio
7.4.5 Ceva Recent Developments
7.5 CAHIC
7.5.1 CAHIC Comapny Information
7.5.2 CAHIC Business Overview
7.5.3 CAHIC Veterinary Vaccine Sales, Revenue, Price and Gross Margin (2019-2024)
7.5.4 CAHIC Veterinary Vaccine Product Portfolio
7.5.5 CAHIC Recent Developments
7.6 HVRI
7.6.1 HVRI Comapny Information
7.6.2 HVRI Business Overview
7.6.3 HVRI Veterinary Vaccine Sales, Revenue, Price and Gross Margin (2019-2024)
7.6.4 HVRI Veterinary Vaccine Product Portfolio
7.6.5 HVRI Recent Developments
7.7 Ringpu Biology
7.7.1 Ringpu Biology Comapny Information
7.7.2 Ringpu Biology Business Overview
7.7.3 Ringpu Biology Veterinary Vaccine Sales, Revenue, Price and Gross Margin (2019-2024)
7.7.4 Ringpu Biology Veterinary Vaccine Product Portfolio
7.7.5 Ringpu Biology Recent Developments
7.8 Yebio
7.8.1 Yebio Comapny Information
7.8.2 Yebio Business Overview
7.8.3 Yebio Veterinary Vaccine Sales, Revenue, Price and Gross Margin (2019-2024)
7.8.4 Yebio Veterinary Vaccine Product Portfolio
7.8.5 Yebio Recent Developments
7.9 DHN
7.9.1 DHN Comapny Information
7.9.2 DHN Business Overview
7.9.3 DHN Veterinary Vaccine Sales, Revenue, Price and Gross Margin (2019-2024)
7.9.4 DHN Veterinary Vaccine Product Portfolio
7.9.5 DHN Recent Developments
7.10 WINSUN
7.10.1 WINSUN Comapny Information
7.10.2 WINSUN Business Overview
7.10.3 WINSUN Veterinary Vaccine Sales, Revenue, Price and Gross Margin (2019-2024)
7.10.4 WINSUN Veterinary Vaccine Product Portfolio
7.10.5 WINSUN Recent Developments
7.11 Elanco
7.11.1 Elanco Comapny Information
7.11.2 Elanco Business Overview
7.11.3 Elanco Veterinary Vaccine Sales, Revenue, Price and Gross Margin (2019-2024)
7.11.4 Elanco Veterinary Vaccine Product Portfolio
7.11.5 Elanco Recent Developments
7.12 Virbac
7.12.1 Virbac Comapny Information
7.12.2 Virbac Business Overview
7.12.3 Virbac Veterinary Vaccine Sales, Revenue, Price and Gross Margin (2019-2024)
7.12.4 Virbac Veterinary Vaccine Product Portfolio
7.12.5 Virbac Recent Developments
7.13 Jinyu Bio-Technology
7.13.1 Jinyu Bio-Technology Comapny Information
7.13.2 Jinyu Bio-Technology Business Overview
7.13.3 Jinyu Bio-Technology Veterinary Vaccine Sales, Revenue, Price and Gross Margin (2019-2024)
7.13.4 Jinyu Bio-Technology Veterinary Vaccine Product Portfolio
7.13.5 Jinyu Bio-Technology Recent Developments
7.14 ChengDu Tecbond
7.14.1 ChengDu Tecbond Comapny Information
7.14.2 ChengDu Tecbond Business Overview
7.14.3 ChengDu Tecbond Veterinary Vaccine Sales, Revenue, Price and Gross Margin (2019-2024)
7.14.4 ChengDu Tecbond Veterinary Vaccine Product Portfolio
7.14.5 ChengDu Tecbond Recent Developments
7.15 CAVAC
7.15.1 CAVAC Comapny Information
7.15.2 CAVAC Business Overview
7.15.3 CAVAC Veterinary Vaccine Sales, Revenue, Price and Gross Margin (2019-2024)
7.15.4 CAVAC Veterinary Vaccine Product Portfolio
7.15.5 CAVAC Recent Developments
7.16 Kyoto Biken Laboratories
7.16.1 Kyoto Biken Laboratories Comapny Information
7.16.2 Kyoto Biken Laboratories Business Overview
7.16.3 Kyoto Biken Laboratories Veterinary Vaccine Sales, Revenue, Price and Gross Margin (2019-2024)
7.16.4 Kyoto Biken Laboratories Veterinary Vaccine Product Portfolio
7.16.5 Kyoto Biken Laboratories Recent Developments
7.17 FATRO
7.17.1 FATRO Comapny Information
7.17.2 FATRO Business Overview
7.17.3 FATRO Veterinary Vaccine Sales, Revenue, Price and Gross Margin (2019-2024)
7.17.4 FATRO Veterinary Vaccine Product Portfolio
7.17.5 FATRO Recent Developments
7.18 Vaksindo
7.18.1 Vaksindo Comapny Information
7.18.2 Vaksindo Business Overview
7.18.3 Vaksindo Veterinary Vaccine Sales, Revenue, Price and Gross Margin (2019-2024)
7.18.4 Vaksindo Veterinary Vaccine Product Portfolio
7.18.5 Vaksindo Recent Developments
7.19 Bio-Labs
7.19.1 Bio-Labs Comapny Information
7.19.2 Bio-Labs Business Overview
7.19.3 Bio-Labs Veterinary Vaccine Sales, Revenue, Price and Gross Margin (2019-2024)
7.19.4 Bio-Labs Veterinary Vaccine Product Portfolio
7.19.5 Bio-Labs Recent Developments
7.20 Avimex Animal Health
7.20.1 Avimex Animal Health Comapny Information
7.20.2 Avimex Animal Health Business Overview
7.20.3 Avimex Animal Health Veterinary Vaccine Sales, Revenue, Price and Gross Margin (2019-2024)
7.20.4 Avimex Animal Health Veterinary Vaccine Product Portfolio
7.20.5 Avimex Animal Health Recent Developments
7.21 MEVAC
7.21.1 MEVAC Comapny Information
7.21.2 MEVAC Business Overview
7.21.3 MEVAC Veterinary Vaccine Sales, Revenue, Price and Gross Margin (2019-2024)
7.21.4 MEVAC Veterinary Vaccine Product Portfolio
7.21.5 MEVAC Recent Developments
7.22 Biovac
7.22.1 Biovac Comapny Information
7.22.2 Biovac Business Overview
7.22.3 Biovac Veterinary Vaccine Sales, Revenue, Price and Gross Margin (2019-2024)
7.22.4 Biovac Veterinary Vaccine Product Portfolio
7.22.5 Biovac Recent Developments
7.23 Atafen
7.23.1 Atafen Comapny Information
7.23.2 Atafen Business Overview
7.23.3 Atafen Veterinary Vaccine Sales, Revenue, Price and Gross Margin (2019-2024)
7.23.4 Atafen Veterinary Vaccine Product Portfolio
7.23.5 Atafen Recent Developments
7.24 Dyntec
7.24.1 Dyntec Comapny Information
7.24.2 Dyntec Business Overview
7.24.3 Dyntec Veterinary Vaccine Sales, Revenue, Price and Gross Margin (2019-2024)
7.24.4 Dyntec Veterinary Vaccine Product Portfolio
7.24.5 Dyntec Recent Developments
7.25 BioTestLab
7.25.1 BioTestLab Comapny Information
7.25.2 BioTestLab Business Overview
7.25.3 BioTestLab Veterinary Vaccine Sales, Revenue, Price and Gross Margin (2019-2024)
7.25.4 BioTestLab Veterinary Vaccine Product Portfolio
7.25.5 BioTestLab Recent Developments
7.26 RVSRI
7.26.1 RVSRI Comapny Information
7.26.2 RVSRI Business Overview
7.26.3 RVSRI Veterinary Vaccine Sales, Revenue, Price and Gross Margin (2019-2024)
7.26.4 RVSRI Veterinary Vaccine Product Portfolio
7.26.5 RVSRI Recent Developments
7.27 Medion
7.27.1 Medion Comapny Information
7.27.2 Medion Business Overview
7.27.3 Medion Veterinary Vaccine Sales, Revenue, Price and Gross Margin (2019-2024)
7.27.4 Medion Veterinary Vaccine Product Portfolio
7.27.5 Medion Recent Developments
8 NORTH AMERICA
8.1 North America Veterinary Vaccine Market Size by Type
8.1.1 North America Veterinary Vaccine Revenue by Type (2019-2030)
8.1.2 North America Veterinary Vaccine Sales by Type (2019-2030)
8.1.3 North America Veterinary Vaccine Price by Type (2019-2030)
8.2 North America Veterinary Vaccine Market Size by Application
8.2.1 North America Veterinary Vaccine Revenue by Application (2019-2030)
8.2.2 North America Veterinary Vaccine Sales by Application (2019-2030)
8.2.3 North America Veterinary Vaccine Price by Application (2019-2030)
8.3 North America Veterinary Vaccine Market Size by Country
8.3.1 North America Veterinary Vaccine Revenue Grow Rate by Country (2019 VS 2023 VS 2030)
8.3.2 North America Veterinary Vaccine Sales by Country (2019 VS 2023 VS 2030)
8.3.3 North America Veterinary Vaccine Price by Country (2019-2030)
8.3.4 U.S.
8.3.5 Canada
9 EUROPE
9.1 Europe Veterinary Vaccine Market Size by Type
9.1.1 Europe Veterinary Vaccine Revenue by Type (2019-2030)
9.1.2 Europe Veterinary Vaccine Sales by Type (2019-2030)
9.1.3 Europe Veterinary Vaccine Price by Type (2019-2030)
9.2 Europe Veterinary Vaccine Market Size by Application
9.2.1 Europe Veterinary Vaccine Revenue by Application (2019-2030)
9.2.2 Europe Veterinary Vaccine Sales by Application (2019-2030)
9.2.3 Europe Veterinary Vaccine Price by Application (2019-2030)
9.3 Europe Veterinary Vaccine Market Size by Country
9.3.1 Europe Veterinary Vaccine Revenue Grow Rate by Country (2019 VS 2023 VS 2030)
9.3.2 Europe Veterinary Vaccine Sales by Country (2019 VS 2023 VS 2030)
9.3.3 Europe Veterinary Vaccine Price by Country (2019-2030)
9.3.4 Germany
9.3.5 France
9.3.6 U.K.
9.3.7 Italy
9.3.8 Russia
10 CHINA
10.1 China Veterinary Vaccine Market Size by Type
10.1.1 China Veterinary Vaccine Revenue by Type (2019-2030)
10.1.2 China Veterinary Vaccine Sales by Type (2019-2030)
10.1.3 China Veterinary Vaccine Price by Type (2019-2030)
10.2 China Veterinary Vaccine Market Size by Application
10.2.1 China Veterinary Vaccine Revenue by Application (2019-2030)
10.2.2 China Veterinary Vaccine Sales by Application (2019-2030)
10.2.3 China Veterinary Vaccine Price by Application (2019-2030)
11 ASIA (EXCLUDING CHINA)
11.1 Asia Veterinary Vaccine Market Size by Type
11.1.1 Asia Veterinary Vaccine Revenue by Type (2019-2030)
11.1.2 Asia Veterinary Vaccine Sales by Type (2019-2030)
11.1.3 Asia Veterinary Vaccine Price by Type (2019-2030)
11.2 Asia Veterinary Vaccine Market Size by Application
11.2.1 Asia Veterinary Vaccine Revenue by Application (2019-2030)
11.2.2 Asia Veterinary Vaccine Sales by Application (2019-2030)
11.2.3 Asia Veterinary Vaccine Price by Application (2019-2030)
11.3 Asia Veterinary Vaccine Market Size by Country
11.3.1 Asia Veterinary Vaccine Revenue Grow Rate by Country (2019 VS 2023 VS 2030)
11.3.2 Asia Veterinary Vaccine Sales by Country (2019 VS 2023 VS 2030)
11.3.3 Asia Veterinary Vaccine Price by Country (2019-2030)
11.3.4 Japan
11.3.5 South Korea
11.3.6 India
11.3.7 Australia
11.3.8 China Taiwan
11.3.9 Southeast Asia
12 MIDDLE EAST, AFRICA AND LATIN AMERICA
12.1 MEALA Veterinary Vaccine Market Size by Type
12.1.1 MEALA Veterinary Vaccine Revenue by Type (2019-2030)
12.1.2 MEALA Veterinary Vaccine Sales by Type (2019-2030)
12.1.3 MEALA Veterinary Vaccine Price by Type (2019-2030)
12.2 MEALA Veterinary Vaccine Market Size by Application
12.2.1 MEALA Veterinary Vaccine Revenue by Application (2019-2030)
12.2.2 MEALA Veterinary Vaccine Sales by Application (2019-2030)
12.2.3 MEALA Veterinary Vaccine Price by Application (2019-2030)
12.3 MEALA Veterinary Vaccine Market Size by Country
12.3.1 MEALA Veterinary Vaccine Revenue Grow Rate by Country (2019 VS 2023 VS 2030)
12.3.2 MEALA Veterinary Vaccine Sales by Country (2019 VS 2023 VS 2030)
12.3.3 MEALA Veterinary Vaccine Price by Country (2019-2030)
12.3.4 Mexico
12.3.5 Brazil
12.3.6 Israel
12.3.7 Argentina
12.3.8 Colombia
12.3.9 Turkey
12.3.10 Saudi Arabia
12.3.11 UAE
13 VALUE CHAIN AND SALES CHANNELS ANALYSIS
13.1 Veterinary Vaccine Value Chain Analysis
13.1.1 Veterinary Vaccine Key Raw Materials
13.1.2 Raw Materials Key Suppliers
13.1.3 Manufacturing Cost Structure
13.1.4 Veterinary Vaccine Production Mode & Process
13.2 Veterinary Vaccine Sales Channels Analysis
13.2.1 Direct Comparison with Distribution Share
13.2.2 Veterinary Vaccine Distributors
13.2.3 Veterinary Vaccine Customers
14 CONCLUDING INSIGHTS
15 APPENDIX
15.1 Reasons for Doing This Study
15.2 Research Methodology
15.3 Research Process
15.4 Authors List of This Report
15.5 Data Source
15.5.1 Secondary Sources
15.5.2 Primary Sources
15.6 Disclaimer
LIST OF TABLES
Table 1. Global Veterinary Vaccine Market Size Growth Rate by Type (US$ Million), 2019 VS 2023 VS 2030
Table 2. Live Attenuated Vaccines Major Manufacturers
Table 3. Inactivated Vaccines Major Manufacturers
Table 4. Others Major Manufacturers
Table 5. Global Veterinary Vaccine Market Size Growth Rate by Application (US$ Million), 2019 VS 2023 VS 2030
Table 6. Livestock Major Manufacturers
Table 7. Swine Major Manufacturers
Table 8. Chicken Major Manufacturers
Table 9. Dog & Cat Major Manufacturers
Table 10. Others Major Manufacturers
Table 11. Veterinary Vaccine Industry Trends
Table 12. Veterinary Vaccine Industry Drivers
Table 13. Veterinary Vaccine Industry Opportunities and Challenges
Table 14. Veterinary Vaccine Industry Restraints
Table 15. Global Veterinary Vaccine Revenue Grow Rate (CAGR) by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 16. Global Veterinary Vaccine Revenue by Region (2019-2024) & (US$ Million)
Table 17. Global Veterinary Vaccine Revenue by Region (2025-2030) & (US$ Million)
Table 18. Global Veterinary Vaccine Revenue Market Share by Region (2019-2024)
Table 19. Global Veterinary Vaccine Revenue Market Share by Region (2025-2030)
Table 20. Global Veterinary Vaccine Sales Grow Rate (CAGR) by Region: 2019 VS 2023 VS 2030 (M Doses)
Table 21. Global Veterinary Vaccine Sales by Region (2019-2024) & (M Doses)
Table 22. Global Veterinary Vaccine Sales by Region (2025-2030) & (M Doses)
Table 23. Global Veterinary Vaccine Sales Market Share by Region (2019-2024)
Table 24. Global Veterinary Vaccine Sales Market Share by Region (2025-2030)
Table 25. Global Veterinary Vaccine Revenue by Manufacturers (US$ Million) & (2019-2024)
Table 26. Global Veterinary Vaccine Revenue Market Share by Manufacturers (2019-2024)
Table 27. Global Veterinary Vaccine Sales by Manufacturers (US$ Million) & (2019-2024)
Table 28. Global Veterinary Vaccine Sales Market Share by Manufacturers (2019-2024)
Table 29. Global Veterinary Vaccine Sales Price (USD/Doses) of Manufacturers (2019-2024)
Table 30. Global Veterinary Vaccine Key Manufacturers Ranking, 2022 VS 2023 VS 2024
Table 31. Global Veterinary Vaccine Key Manufacturers Manufacturing Sites & Headquarters
Table 32. Global Veterinary Vaccine Manufacturers, Product Type & Application
Table 33. Global Veterinary Vaccine Manufacturers Commercialization Time
Table 34. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 35. Global Veterinary Vaccine by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2023)
Table 36. Global Veterinary Vaccine Revenue by Type 2019 VS 2023 VS 2030 (US$ Million)
Table 37. Global Veterinary Vaccine Revenue by Type (2019-2024) & (US$ Million)
Table 38. Global Veterinary Vaccine Revenue by Type (2025-2030) & (US$ Million)
Table 39. Global Veterinary Vaccine Revenue Market Share by Type (2019-2024)
Table 40. Global Veterinary Vaccine Revenue Market Share by Type (2025-2030)
Table 41. Global Veterinary Vaccine Sales by Type 2019 VS 2023 VS 2030 (M Doses)
Table 42. Global Veterinary Vaccine Sales by Type (2019-2024) & (M Doses)
Table 43. Global Veterinary Vaccine Sales by Type (2025-2030) & (M Doses)
Table 44. Global Veterinary Vaccine Sales Market Share by Type (2019-2024)
Table 45. Global Veterinary Vaccine Sales Market Share by Type (2025-2030)
Table 46. Global Veterinary Vaccine Price by Type (2019-2024) & (USD/Doses)
Table 47. Global Veterinary Vaccine Price by Type (2025-2030) & (USD/Doses)
Table 48. Global Veterinary Vaccine Revenue by Application 2019 VS 2023 VS 2030 (US$ Million)
Table 49. Global Veterinary Vaccine Revenue by Application (2019-2024) & (US$ Million)
Table 50. Global Veterinary Vaccine Revenue by Application (2025-2030) & (US$ Million)
Table 51. Global Veterinary Vaccine Revenue Market Share by Application (2019-2024)
Table 52. Global Veterinary Vaccine Revenue Market Share by Application (2025-2030)
Table 53. Global Veterinary Vaccine Sales by Application 2019 VS 2023 VS 2030 (M Doses)
Table 54. Global Veterinary Vaccine Sales by Application (2019-2024) & (M Doses)
Table 55. Global Veterinary Vaccine Sales by Application (2025-2030) & (M Doses)
Table 56. Global Veterinary Vaccine Sales Market Share by Application (2019-2024)
Table 57. Global Veterinary Vaccine Sales Market Share by Application (2025-2030)
Table 58. Global Veterinary Vaccine Price by Application (2019-2024) & (USD/Doses)
Table 59. Global Veterinary Vaccine Price by Application (2025-2030) & (USD/Doses)
Table 60. Merck Company Information
Table 61. Merck Business Overview
Table 62. Merck Veterinary Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2019-2024)
Table 63. Merck Veterinary Vaccine Product Portfolio
Table 64. Merck Recent Development
Table 65. Zoetis Company Information
Table 66. Zoetis Business Overview
Table 67. Zoetis Veterinary Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2019-2024)
Table 68. Zoetis Veterinary Vaccine Product Portfolio
Table 69. Zoetis Recent Development
Table 70. Boehringer Ingelheim Company Information
Table 71. Boehringer Ingelheim Business Overview
Table 72. Boehringer Ingelheim Veterinary Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2019-2024)
Table 73. Boehringer Ingelheim Veterinary Vaccine Product Portfolio
Table 74. Boehringer Ingelheim Recent Development
Table 75. Ceva Company Information
Table 76. Ceva Business Overview
Table 77. Ceva Veterinary Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2019-2024)
Table 78. Ceva Veterinary Vaccine Product Portfolio
Table 79. Ceva Recent Development
Table 80. CAHIC Company Information
Table 81. CAHIC Business Overview
Table 82. CAHIC Veterinary Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2019-2024)
Table 83. CAHIC Veterinary Vaccine Product Portfolio
Table 84. CAHIC Recent Development
Table 85. HVRI Company Information
Table 86. HVRI Business Overview
Table 87. HVRI Veterinary Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2019-2024)
Table 88. HVRI Veterinary Vaccine Product Portfolio
Table 89. HVRI Recent Development
Table 90. Ringpu Biology Company Information
Table 91. Ringpu Biology Business Overview
Table 92. Ringpu Biology Veterinary Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2019-2024)
Table 93. Ringpu Biology Veterinary Vaccine Product Portfolio
Table 94. Ringpu Biology Recent Development
Table 95. Yebio Company Information
Table 96. Yebio Business Overview
Table 97. Yebio Veterinary Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2019-2024)
Table 98. Yebio Veterinary Vaccine Product Portfolio
Table 99. Yebio Recent Development
Table 100. DHN Company Information
Table 101. DHN Business Overview
Table 102. DHN Veterinary Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2019-2024)
Table 103. DHN Veterinary Vaccine Product Portfolio
Table 104. DHN Recent Development
Table 105. WINSUN Company Information
Table 106. WINSUN Business Overview
Table 107. WINSUN Veterinary Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2019-2024)
Table 108. WINSUN Veterinary Vaccine Product Portfolio
Table 109. WINSUN Recent Development
Table 110. Elanco Company Information
Table 111. Elanco Business Overview
Table 112. Elanco Veterinary Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2019-2024)
Table 113. Elanco Veterinary Vaccine Product Portfolio
Table 114. Elanco Recent Development
Table 115. Virbac Company Information
Table 116. Virbac Business Overview
Table 117. Virbac Veterinary Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2019-2024)
Table 118. Virbac Veterinary Vaccine Product Portfolio
Table 119. Virbac Recent Development
Table 120. Jinyu Bio-Technology Company Information
Table 121. Jinyu Bio-Technology Business Overview
Table 122. Jinyu Bio-Technology Veterinary Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2019-2024)
Table 123. Jinyu Bio-Technology Veterinary Vaccine Product Portfolio
Table 124. Jinyu Bio-Technology Recent Development
Table 125. ChengDu Tecbond Company Information
Table 126. ChengDu Tecbond Business Overview
Table 127. ChengDu Tecbond Veterinary Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2019-2024)
Table 128. ChengDu Tecbond Veterinary Vaccine Product Portfolio
Table 129. ChengDu Tecbond Recent Development
Table 130. CAVAC Company Information
Table 131. CAVAC Business Overview
Table 132. CAVAC Veterinary Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2019-2024)
Table 133. CAVAC Veterinary Vaccine Product Portfolio
Table 134. CAVAC Recent Development
Table 135. Kyoto Biken Laboratories Company Information
Table 136. Kyoto Biken Laboratories Business Overview
Table 137. Kyoto Biken Laboratories Veterinary Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2019-2024)
Table 138. Kyoto Biken Laboratories Veterinary Vaccine Product Portfolio
Table 139. Kyoto Biken Laboratories Recent Development
Table 140. FATRO Company Information
Table 141. FATRO Business Overview
Table 142. FATRO Veterinary Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2019-2024)
Table 143. FATRO Veterinary Vaccine Product Portfolio
Table 144. FATRO Recent Development
Table 145. Vaksindo Company Information
Table 146. Vaksindo Business Overview
Table 147. Vaksindo Veterinary Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2019-2024)
Table 148. Vaksindo Veterinary Vaccine Product Portfolio
Table 149. Vaksindo Recent Development
Table 150. Bio-Labs Company Information
Table 151. Bio-Labs Business Overview
Table 152. Bio-Labs Veterinary Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2019-2024)
Table 153. Bio-Labs Veterinary Vaccine Product Portfolio
Table 154. Bio-Labs Recent Development
Table 155. Avimex Animal Health Company Information
Table 156. Avimex Animal Health Business Overview
Table 157. Avimex Animal Health Veterinary Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2019-2024)
Table 158. Avimex Animal Health Veterinary Vaccine Product Portfolio
Table 159. Avimex Animal Health Recent Development
Table 160. MEVAC Company Information
Table 161. MEVAC Business Overview
Table 162. MEVAC Veterinary Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2019-2024)
Table 163. MEVAC Veterinary Vaccine Product Portfolio
Table 164. MEVAC Recent Development
Table 165. Biovac Company Information
Table 166. Biovac Business Overview
Table 167. Biovac Veterinary Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2019-2024)
Table 168. Biovac Veterinary Vaccine Product Portfolio
Table 169. Biovac Recent Development
Table 170. Atafen Company Information
Table 171. Atafen Business Overview
Table 172. Atafen Veterinary Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2019-2024)
Table 173. Atafen Veterinary Vaccine Product Portfolio
Table 174. Atafen Recent Development
Table 175. Dyntec Company Information
Table 176. Dyntec Business Overview
Table 177. Dyntec Veterinary Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2019-2024)
Table 178. Dyntec Veterinary Vaccine Product Portfolio
Table 179. Dyntec Recent Development
Table 180. BioTestLab Company Information
Table 181. BioTestLab Business Overview
Table 182. BioTestLab Veterinary Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2019-2024)
Table 183. BioTestLab Veterinary Vaccine Product Portfolio
Table 184. BioTestLab Recent Development
Table 185. RVSRI Company Information
Table 186. RVSRI Business Overview
Table 187. RVSRI Veterinary Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2019-2024)
Table 188. RVSRI Veterinary Vaccine Product Portfolio
Table 189. RVSRI Recent Development
Table 190. Medion Company Information
Table 191. Medion Business Overview
Table 192. Medion Veterinary Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2019-2024)
Table 193. Medion Veterinary Vaccine Product Portfolio
Table 194. Medion Recent Development
Table 195. North America Veterinary Vaccine Revenue by Type (2019-2024) & (US$ Million)
Table 196. North America Veterinary Vaccine Revenue by Type (2025-2030) & (US$ Million)
Table 197. North America Veterinary Vaccine Sales by Type (2019-2024) & (M Doses)
Table 198. North America Veterinary Vaccine Sales by Type (2025-2030) & (M Doses)
Table 199. North America Veterinary Vaccine Sales Price by Type (2019-2024) & (USD/Doses)
Table 200. North America Veterinary Vaccine Sales Price by Type (2025-2030) & (USD/Doses)
Table 201. North Americ
Table 1. Global Veterinary Vaccine Market Size Growth Rate by Type (US$ Million), 2019 VS 2023 VS 2030
Table 2. Live Attenuated Vaccines Major Manufacturers
Table 3. Inactivated Vaccines Major Manufacturers
Table 4. Others Major Manufacturers
Table 5. Global Veterinary Vaccine Market Size Growth Rate by Application (US$ Million), 2019 VS 2023 VS 2030
Table 6. Livestock Major Manufacturers
Table 7. Swine Major Manufacturers
Table 8. Chicken Major Manufacturers
Table 9. Dog & Cat Major Manufacturers
Table 10. Others Major Manufacturers
Table 11. Veterinary Vaccine Industry Trends
Table 12. Veterinary Vaccine Industry Drivers
Table 13. Veterinary Vaccine Industry Opportunities and Challenges
Table 14. Veterinary Vaccine Industry Restraints
Table 15. Global Veterinary Vaccine Revenue Grow Rate (CAGR) by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 16. Global Veterinary Vaccine Revenue by Region (2019-2024) & (US$ Million)
Table 17. Global Veterinary Vaccine Revenue by Region (2025-2030) & (US$ Million)
Table 18. Global Veterinary Vaccine Revenue Market Share by Region (2019-2024)
Table 19. Global Veterinary Vaccine Revenue Market Share by Region (2025-2030)
Table 20. Global Veterinary Vaccine Sales Grow Rate (CAGR) by Region: 2019 VS 2023 VS 2030 (M Doses)
Table 21. Global Veterinary Vaccine Sales by Region (2019-2024) & (M Doses)
Table 22. Global Veterinary Vaccine Sales by Region (2025-2030) & (M Doses)
Table 23. Global Veterinary Vaccine Sales Market Share by Region (2019-2024)
Table 24. Global Veterinary Vaccine Sales Market Share by Region (2025-2030)
Table 25. Global Veterinary Vaccine Revenue by Manufacturers (US$ Million) & (2019-2024)
Table 26. Global Veterinary Vaccine Revenue Market Share by Manufacturers (2019-2024)
Table 27. Global Veterinary Vaccine Sales by Manufacturers (US$ Million) & (2019-2024)
Table 28. Global Veterinary Vaccine Sales Market Share by Manufacturers (2019-2024)
Table 29. Global Veterinary Vaccine Sales Price (USD/Doses) of Manufacturers (2019-2024)
Table 30. Global Veterinary Vaccine Key Manufacturers Ranking, 2022 VS 2023 VS 2024
Table 31. Global Veterinary Vaccine Key Manufacturers Manufacturing Sites & Headquarters
Table 32. Global Veterinary Vaccine Manufacturers, Product Type & Application
Table 33. Global Veterinary Vaccine Manufacturers Commercialization Time
Table 34. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 35. Global Veterinary Vaccine by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2023)
Table 36. Global Veterinary Vaccine Revenue by Type 2019 VS 2023 VS 2030 (US$ Million)
Table 37. Global Veterinary Vaccine Revenue by Type (2019-2024) & (US$ Million)
Table 38. Global Veterinary Vaccine Revenue by Type (2025-2030) & (US$ Million)
Table 39. Global Veterinary Vaccine Revenue Market Share by Type (2019-2024)
Table 40. Global Veterinary Vaccine Revenue Market Share by Type (2025-2030)
Table 41. Global Veterinary Vaccine Sales by Type 2019 VS 2023 VS 2030 (M Doses)
Table 42. Global Veterinary Vaccine Sales by Type (2019-2024) & (M Doses)
Table 43. Global Veterinary Vaccine Sales by Type (2025-2030) & (M Doses)
Table 44. Global Veterinary Vaccine Sales Market Share by Type (2019-2024)
Table 45. Global Veterinary Vaccine Sales Market Share by Type (2025-2030)
Table 46. Global Veterinary Vaccine Price by Type (2019-2024) & (USD/Doses)
Table 47. Global Veterinary Vaccine Price by Type (2025-2030) & (USD/Doses)
Table 48. Global Veterinary Vaccine Revenue by Application 2019 VS 2023 VS 2030 (US$ Million)
Table 49. Global Veterinary Vaccine Revenue by Application (2019-2024) & (US$ Million)
Table 50. Global Veterinary Vaccine Revenue by Application (2025-2030) & (US$ Million)
Table 51. Global Veterinary Vaccine Revenue Market Share by Application (2019-2024)
Table 52. Global Veterinary Vaccine Revenue Market Share by Application (2025-2030)
Table 53. Global Veterinary Vaccine Sales by Application 2019 VS 2023 VS 2030 (M Doses)
Table 54. Global Veterinary Vaccine Sales by Application (2019-2024) & (M Doses)
Table 55. Global Veterinary Vaccine Sales by Application (2025-2030) & (M Doses)
Table 56. Global Veterinary Vaccine Sales Market Share by Application (2019-2024)
Table 57. Global Veterinary Vaccine Sales Market Share by Application (2025-2030)
Table 58. Global Veterinary Vaccine Price by Application (2019-2024) & (USD/Doses)
Table 59. Global Veterinary Vaccine Price by Application (2025-2030) & (USD/Doses)
Table 60. Merck Company Information
Table 61. Merck Business Overview
Table 62. Merck Veterinary Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2019-2024)
Table 63. Merck Veterinary Vaccine Product Portfolio
Table 64. Merck Recent Development
Table 65. Zoetis Company Information
Table 66. Zoetis Business Overview
Table 67. Zoetis Veterinary Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2019-2024)
Table 68. Zoetis Veterinary Vaccine Product Portfolio
Table 69. Zoetis Recent Development
Table 70. Boehringer Ingelheim Company Information
Table 71. Boehringer Ingelheim Business Overview
Table 72. Boehringer Ingelheim Veterinary Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2019-2024)
Table 73. Boehringer Ingelheim Veterinary Vaccine Product Portfolio
Table 74. Boehringer Ingelheim Recent Development
Table 75. Ceva Company Information
Table 76. Ceva Business Overview
Table 77. Ceva Veterinary Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2019-2024)
Table 78. Ceva Veterinary Vaccine Product Portfolio
Table 79. Ceva Recent Development
Table 80. CAHIC Company Information
Table 81. CAHIC Business Overview
Table 82. CAHIC Veterinary Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2019-2024)
Table 83. CAHIC Veterinary Vaccine Product Portfolio
Table 84. CAHIC Recent Development
Table 85. HVRI Company Information
Table 86. HVRI Business Overview
Table 87. HVRI Veterinary Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2019-2024)
Table 88. HVRI Veterinary Vaccine Product Portfolio
Table 89. HVRI Recent Development
Table 90. Ringpu Biology Company Information
Table 91. Ringpu Biology Business Overview
Table 92. Ringpu Biology Veterinary Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2019-2024)
Table 93. Ringpu Biology Veterinary Vaccine Product Portfolio
Table 94. Ringpu Biology Recent Development
Table 95. Yebio Company Information
Table 96. Yebio Business Overview
Table 97. Yebio Veterinary Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2019-2024)
Table 98. Yebio Veterinary Vaccine Product Portfolio
Table 99. Yebio Recent Development
Table 100. DHN Company Information
Table 101. DHN Business Overview
Table 102. DHN Veterinary Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2019-2024)
Table 103. DHN Veterinary Vaccine Product Portfolio
Table 104. DHN Recent Development
Table 105. WINSUN Company Information
Table 106. WINSUN Business Overview
Table 107. WINSUN Veterinary Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2019-2024)
Table 108. WINSUN Veterinary Vaccine Product Portfolio
Table 109. WINSUN Recent Development
Table 110. Elanco Company Information
Table 111. Elanco Business Overview
Table 112. Elanco Veterinary Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2019-2024)
Table 113. Elanco Veterinary Vaccine Product Portfolio
Table 114. Elanco Recent Development
Table 115. Virbac Company Information
Table 116. Virbac Business Overview
Table 117. Virbac Veterinary Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2019-2024)
Table 118. Virbac Veterinary Vaccine Product Portfolio
Table 119. Virbac Recent Development
Table 120. Jinyu Bio-Technology Company Information
Table 121. Jinyu Bio-Technology Business Overview
Table 122. Jinyu Bio-Technology Veterinary Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2019-2024)
Table 123. Jinyu Bio-Technology Veterinary Vaccine Product Portfolio
Table 124. Jinyu Bio-Technology Recent Development
Table 125. ChengDu Tecbond Company Information
Table 126. ChengDu Tecbond Business Overview
Table 127. ChengDu Tecbond Veterinary Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2019-2024)
Table 128. ChengDu Tecbond Veterinary Vaccine Product Portfolio
Table 129. ChengDu Tecbond Recent Development
Table 130. CAVAC Company Information
Table 131. CAVAC Business Overview
Table 132. CAVAC Veterinary Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2019-2024)
Table 133. CAVAC Veterinary Vaccine Product Portfolio
Table 134. CAVAC Recent Development
Table 135. Kyoto Biken Laboratories Company Information
Table 136. Kyoto Biken Laboratories Business Overview
Table 137. Kyoto Biken Laboratories Veterinary Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2019-2024)
Table 138. Kyoto Biken Laboratories Veterinary Vaccine Product Portfolio
Table 139. Kyoto Biken Laboratories Recent Development
Table 140. FATRO Company Information
Table 141. FATRO Business Overview
Table 142. FATRO Veterinary Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2019-2024)
Table 143. FATRO Veterinary Vaccine Product Portfolio
Table 144. FATRO Recent Development
Table 145. Vaksindo Company Information
Table 146. Vaksindo Business Overview
Table 147. Vaksindo Veterinary Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2019-2024)
Table 148. Vaksindo Veterinary Vaccine Product Portfolio
Table 149. Vaksindo Recent Development
Table 150. Bio-Labs Company Information
Table 151. Bio-Labs Business Overview
Table 152. Bio-Labs Veterinary Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2019-2024)
Table 153. Bio-Labs Veterinary Vaccine Product Portfolio
Table 154. Bio-Labs Recent Development
Table 155. Avimex Animal Health Company Information
Table 156. Avimex Animal Health Business Overview
Table 157. Avimex Animal Health Veterinary Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2019-2024)
Table 158. Avimex Animal Health Veterinary Vaccine Product Portfolio
Table 159. Avimex Animal Health Recent Development
Table 160. MEVAC Company Information
Table 161. MEVAC Business Overview
Table 162. MEVAC Veterinary Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2019-2024)
Table 163. MEVAC Veterinary Vaccine Product Portfolio
Table 164. MEVAC Recent Development
Table 165. Biovac Company Information
Table 166. Biovac Business Overview
Table 167. Biovac Veterinary Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2019-2024)
Table 168. Biovac Veterinary Vaccine Product Portfolio
Table 169. Biovac Recent Development
Table 170. Atafen Company Information
Table 171. Atafen Business Overview
Table 172. Atafen Veterinary Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2019-2024)
Table 173. Atafen Veterinary Vaccine Product Portfolio
Table 174. Atafen Recent Development
Table 175. Dyntec Company Information
Table 176. Dyntec Business Overview
Table 177. Dyntec Veterinary Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2019-2024)
Table 178. Dyntec Veterinary Vaccine Product Portfolio
Table 179. Dyntec Recent Development
Table 180. BioTestLab Company Information
Table 181. BioTestLab Business Overview
Table 182. BioTestLab Veterinary Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2019-2024)
Table 183. BioTestLab Veterinary Vaccine Product Portfolio
Table 184. BioTestLab Recent Development
Table 185. RVSRI Company Information
Table 186. RVSRI Business Overview
Table 187. RVSRI Veterinary Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2019-2024)
Table 188. RVSRI Veterinary Vaccine Product Portfolio
Table 189. RVSRI Recent Development
Table 190. Medion Company Information
Table 191. Medion Business Overview
Table 192. Medion Veterinary Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2019-2024)
Table 193. Medion Veterinary Vaccine Product Portfolio
Table 194. Medion Recent Development
Table 195. North America Veterinary Vaccine Revenue by Type (2019-2024) & (US$ Million)
Table 196. North America Veterinary Vaccine Revenue by Type (2025-2030) & (US$ Million)
Table 197. North America Veterinary Vaccine Sales by Type (2019-2024) & (M Doses)
Table 198. North America Veterinary Vaccine Sales by Type (2025-2030) & (M Doses)
Table 199. North America Veterinary Vaccine Sales Price by Type (2019-2024) & (USD/Doses)
Table 200. North America Veterinary Vaccine Sales Price by Type (2025-2030) & (USD/Doses)
Table 201. North Americ
